文献速递胸部介入CT

COVID-19疫情期间影像引导肺癌介入的COVID防护路径:队列研究

COVID-protected pathways for image-guided lung cancer intervention during the COVID-19 pandemic: A cohort study.
PubMed 文献 · Br J Radiol · 2022-11-01

该队列研究比较了COVID-19疫情期间在三级转诊医院采用COVID防护路径与混合队列路径进行择期CT引导肺活检和消融的COVID-19传播情况。结果显示混合站点方法在预防院内COVID-19感染方面可行,可作为大流行期间择期手术管理的实用方法。

要点

  • 混合站点感染控制方法可预防院内COVID-19感染。
  • 择期CT引导肺活检和消融在疫情期间可安全开展。
  • 术后30天随访未发现COVID-19阳性病例(Site 2)。

诊断标准与关键数值

  • Site 1和Site 2分别有2.4%的患者在术后10天和14天检测COVID-19阳性。
  • Site 2在择期胸部介入术后30天内无COVID-19阳性病例。

局限性

  • 研究设计为队列研究,非随机对照,可能存在选择偏倚。
  • 样本量未报告,可能影响统计效力。
  • 单中心研究(Site 1)和另一中心(Site 2),结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compare the experience of COVID-protected and mixed cohort pathways in COVID-19 transmission at a tertiary referral hospital for elective CT-guided lung biopsy and ablation during the COVID-19 pandemic.

METHODS: From September 2020 to August 2021, patients admitted for elective thoracic intervention were treated at a tertiary hospital (Site 1). Site 1 received patients for extracorporeal membrane oxygenation (ECMO) and invasive ventilation in the treatment of COVID-19. Shared imaging, theater, and hallway facilities were used.From April 2020 to August 2020, patients admitted for elective thoracic intervention were treated at a COVID-protected hospital (Site 2). No patients with suspected or confirmed COVID-19 were treated at Site 2.Patients were surveyed for clinical and laboratory signs of COVID-19 infection up to 30 days post-procedure.

RESULTS: At Sites 1 and 2, patients (2.4%) were tested positive for COVID-19 at 10 and 14 days post-procedure.At Site 2, there were no COVID-19 positive cases within 30 days of undergoing elective thoracic intervention.

CONCLUSION: A mixed-site method for infection control could represent a pragmatic approach to the management of elective procedures during the COVID-19 pandemic or for similar illnesses.

ADVANCES IN KNOWLEDGE: Mixed-cohort infection control is possible in the prevention of nosocomial COVID-19 infection.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Sheeka, Singaravelou, Bartlett, et al. COVID-protected pathways for image-guided lung cancer intervention during the COVID-19 pandemic: A cohort study. Br J Radiol. 2022. PMID: 36193768. doi:10.1259/bjr.20220191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。